Tag: Patient Risk

How perioperative staff can combat human trafficking—Part 1

Human trafficking (HT) is a global public health crisis and one of the fastest growing criminal enterprises that grosses hundreds of billions of dollars annually, all of which are tax-free profits made off the sale of human cargo. And yet, research shows the problem is poorly understood or recognized among…

Read More

By: Francine Bono-Neri, PhD, RN, APRN, PNP
August 28, 2024
Share

Study: Uterus transplant associated with high birth rates, but significant risks

JAMA (healthcare publication) Network logo

Editor's Note Uterus transplants are feasible, but the procedure is associated with considerable risks for both patient and organ donor, according to a study published August 15 in JAMA.   Conducted at a large US tertiary care center, the study involved 20 women with absolute uterine-factor infertility—a condition that prevents…

Read More

By: Matt Danford
August 16, 2024
Share

FDA announces Class 1 recalls for nerve monitoring system, ambulatory infusion pumps

Editor's Note The US Food and Drug Administration (FDA) designated recalls of Medtronic’s NIM Vital Nerve Monitoring System and Smith Medical’s CADD-Solis Ambulatory Infusion Pumps as Class 1, the most severe category indicating serious risk of injury or death. Reports of false negative responses prompted Medtronic to recall the nerve…

Read More

By: Matt Danford
August 7, 2024
Share

Study: Intraoperative DEX infusions effectively manage diabetes in cardiac surgery patients

Editor's Note Intraoperative infusion of dexmedetomidine (DEX) could help improve glycemic control and reduce insulin requirements in diabetic patients undergoing cardiac surgery, according to a July 25 article in Medical Dialogues. The article focuses on a prospective observational study published in the journal Annals of Cardiac Anesthesia. The study included…

Read More

By: Matt Danford
July 29, 2024
Share

FDA announces Class 1 recalls of ventilator, eye injection kits

Editor's Note The US Food & Drug Administration has designated recalls of Baxter’s Life2000 Ventilator and the I-Pack Injection Kit from Bausch + Lomb and subsidiary Synergetics Inc. as Class 1, the most severe category indicating serious risk of injury or death. According to FDA’s July 15 announcement, the ventilator…

Read More

By: Matt Danford
July 16, 2024
Share

Study: Gastric bypass offers cardiovascular benefits regardless of weight loss

Editor's Note Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent of calorie restriction and weight loss, according to a recent study published in JAMA Surgery. News-Medical.Net reported on the study July 4. Bariatric surgery, particularly RYGB, is more effective than non-surgical treatments for significant weight reduction and lowering cardiovascular…

Read More

By: Matt Danford
July 15, 2024
Share

Study: Secondary conditions go unaddressed in female heart surgery patients

Editor's Note Female patients undergoing heart surgery are less likely than male patients to have concomitant procedures—that is, having additional ailments addressed during cardiac procedures—despite guidelines recommending such treatments, according to two studies led by Michigan Medicine. News-Medical.Net reported the news June 28. The first study, involving over 5,000 patients…

Read More

By: Matt Danford
July 3, 2024
Share

FDA announces Class 1 recalls for ventilators, LVAS monitors

Editor's Note The US Food and Drug Administration has announced class 1 recalls—the most severe category indicating risk of serious injury or death—for Abbot Medical’s HeartMate System Monitor and Philips Respironics OmniLab Advanced+ (OLA+) ventilator. According to the agency’s June 28 report, the recall of the HeartMate System Monitor, part…

Read More

By: Matt Danford
July 1, 2024
Share

Standardized handoff protocol improves OR communication

Editor's Note Findings published in the Journal of the American College of Surgeons show how a standardized handoff protocol can improve OR communication and reduce the risk of error, Medical Xpress reported on June 19. The study focused specifically on SHRIMPS, a standardized handoff protocol developed by the quality improvement…

Read More

By: Matt Danford
June 28, 2024
Share

FDA issues Class 1 recalls for two ventilator models

Editor's Note Alarm failures and missing details in instructional materials prompted the US Food and Drug Administration (FDA) to issue class 1 recalls—the most severe category indicating risk of serious injury or death—for two different ventilator models on June 27. According to the report, failure in the Ventilator Inoperative alarm…

Read More

By: Matt Danford
June 28, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat